Graduation arc · Disease Cure Research · Invent Deposition #2316 (2017) → 300-Disease Mechanism Analysis — Proof of Function #1

The 2017 seed-line

In 2017, the entry that became 300-Disease Mechanism Analysis — Proof of Function #1 was written down as Invent Deposition #2316:

“Answer to a questionable theory by a hypothetical proof may be the hope that people need to find a cure for any know disease or virus copyright (c) patent pending 2012-2018 chris gabriel brown.”— © 2017 Christopher Gabriel Brown

What changed between 2017 and the product on the shelf

What started as a 2017 one-liner about studying disease mechanisms at scale has hardened into a 300-row mechanism-analysis database. Each row is a candidate disease driver; each column is a molecular pathway, scored under closed-loop, design-target conditions. The Proof of Function exposes the database schema, the scoring rubric, and the redaction layer — enough for a partner team to evaluate scope without seeing the raw IP. Full acquisition transfers the underlying patent-pending filings and prior-art binder. Patent-pending; design targets only.

Where it sits in the four-step framework

• Proof of Function — this article’s SKU. A working write-up against representative inputs; available for licensing review at 300-Disease Mechanism Analysis — Proof of Function #1.
• Tech Validation — bench data and reproducibility under an evaluation licence.
• Eval Licence — supervised use of the IP package by a partner team.
• Full Acquisition — the patent application, prior-art binder, and prosecution file transfer in full.

→ Open the Proof of Function: 300-Disease Mechanism Analysis — Proof of Function #1

Provenance: published 2017 in the Invent Depositions collection (Invent Deposition #2316); part of an intellectual-property portfolio with U.S. patent applications dating to 2012; independently timestamped by the Internet Archive. Patent-pending. Design targets, not warranted performance. First to market — documented public offering, not a determination of patent priority.